Characterising meaningful patient and public involvement in the pharmaceutical industry research setting: a retrospective quality assessment.

ABSTRACT:

Objectives

Patient and public involvement (PPI) in clinical research has a well-established infrastructure in the UK, and while there has been good progress within pharmaceutical-industry-sponsored research, further improvements are still needed. This review aims to share learnings from quality assessments of historical PPI projects within Pfizer UK to inform future projects and drive PPI progress in the pharmaceutical industry.

Design and setting

Internal assessments of Pfizer UK PPI projects were conducted to identify all relevant projects across the medicines development continuum between 2017 and 2021. Five sample projects were developed into case studies.

Outcome measure

Retrospective quality assessments were performed using the Patient Focused Medicines Developm

SUBMITTER: Dews SA 

PROVIDER: S-EPMC10450071 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature